Steroidal CYP17 Inhibitors for Prostate Cancer Treatment: From Concept to Clinic

doi 10.5772/52290
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

Cyp17 Polymorphisms and Prostate Cancer Outcomes

Journal of Urology
Urology
2009English

Promising Tools in Prostate Cancer Research: Selective Non-Steroidal Cytochrome P450 17A1 Inhibitors

Scientific Reports
Multidisciplinary
2016English

A Novel Nonsense Mutation in Androgen Receptor Confers Resistance to CYP17 Inhibitor Treatment in Prostate Cancer

Oncotarget
Oncology
2016English

Prostate Cancer: From Diagnosis to Treatment

Onkourologiya
OncologyRadiologyUrologyNuclear MedicineNephrologyImagingSurgery
2019English

PARP Inhibitors and Stratified Treatment of Prostate Cancer

Expert Review of Anticancer Therapy
OncologyPharmacology
2016English

Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer

Biomedicines
BiochemistryMedicineGeneticsMolecular Biology
2020English

From Concept to Implementation of Community Health Clinic

Journal of Global Health Science
2019English

Conversion From Active Surveillance to Active Treatment for Prostate Cancer: A Qualitative Analysis

Journal of Nursing Education and Practice
2012English

Stereotactic Body Radiation Therapy Treatment for Prostate Cancer: From Setup to Delivery Strategies

Radiology - Open Journal
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy